Skip to main content
India Glycols Ltd logo

India Glycols Ltd — Investor Relations & Filings

Ticker · INDIAGLYCO ISIN · INE560A01023 LEI · 3358002YVDZUMPZLN823 BSE.NS Manufacturing
Open in API
Filings indexed 1,575 across all filing types
Latest filing 2025-05-09 Call Transcript
Country IN India
Listing BSE.NS INDIAGLYCO

About India Glycols Ltd

https://www.indiaglycols.com/

India Glycols Ltd is a pioneer in the manufacturing of green technology-based chemicals. The company specializes in producing bio-based glycols, including monoethylene glycol (MEG), diethylene glycol (DEG), and triethylene glycol (TEG), utilizing renewable feedstock such as molasses. Its product portfolio extends to ethylene oxide derivatives, surfactants, and performance chemicals tailored for diverse applications in textiles, personal care, and oil and gas. Additionally, the company operates in the natural gums, industrial gases, and nutraceuticals sectors. IGL is recognized for its commitment to sustainable chemistry, being the first globally to commercialize the production of ethylene oxide and glycols from bio-ethanol. Its operations also include the production of extra neutral alcohol and high-quality spirits, serving both industrial and consumer markets with a focus on eco-friendly processes.

Recent filings

Filing Released Lang Actions
Updates
Call Transcript Classification · 85% confidence The document is a notification about an upcoming earnings conference call for Q4 and full year FY25, including details on the date, time, and speakers. It is a disclosure under SEBI regulations informing about the earnings call event, not the earnings release itself or a transcript. The document length is short (2276 characters) and it does not contain any financial data or results. Therefore, it is best classified as a Call Transcript (CT) related announcement or invitation. However, since it is only an invitation and not the transcript, the closest fitting category is Call Transcript (CT) as it pertains directly to the earnings call event.
2025-05-09 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a formal letter from India Glycols Limited addressed to stock exchanges, informing about the scheduling of an earnings conference call for Q4 and full year FY25. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates disclosure of material events. The document includes details about the date and time of the earnings call, speakers from management, and contact information for further inquiries. There is no actual financial data or detailed financial report included, only an announcement of the upcoming earnings call event. The document length is short (2276 characters), and it serves as an invitation or notice rather than the transcript or report itself. Therefore, this document is best classified as a Call Transcript (CT) announcement or invitation. However, since it is only an announcement of the earnings conference call and not the transcript itself, the closest fitting category is Regulatory Filings (RNS) as a general regulatory announcement about the earnings call event, because the actual transcript or earnings release is not included here.
2025-05-09 English
Trading Window
Board/Management Information Classification · 95% confidence The document is a notice of an upcoming Board Meeting scheduled for 16th May 2025 to consider and approve the Audited Financial Results for the quarter and financial year ended 31st March 2025, and to recommend dividends. It is a formal announcement pursuant to SEBI regulations about the meeting date and agenda, including trading window closure details. The document does not contain the financial results themselves, nor detailed financial data or analysis. It is an announcement of a board meeting and related procedural information, not the actual report or results. Therefore, it fits best under Board/Management Information (MANG). The document length is short (1817 characters), consistent with a meeting notice rather than a full report.
2025-05-09 English
Updates
Board/Management Information Classification · 95% confidence The document is a notice of a forthcoming Board Meeting scheduled for 16th May 2025 to consider and approve the Audited Financial Results for the quarter and financial year ended 31st March 2025, and to recommend dividend if any. It is issued pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosures related to board meetings. The document does not contain the financial results themselves but is an announcement of the meeting where such results will be approved. The document length is short (1817 characters) and it serves as an official notification to stock exchanges and the public about the board meeting and trading window closure. Therefore, it is best classified as a Board/Management Information (MANG) filing, which covers announcements of board meetings and related management information.
2025-05-09 English
Board Meeting — Financial Results/Dividend
Regulatory Filings Classification · 95% confidence The document is a notice of a forthcoming Board Meeting scheduled for 16th May 2025 to consider and approve the Audited Financial Results for the quarter and financial year ended 31st March 2025, along with dividend recommendation. It is a formal announcement pursuant to regulatory requirements (SEBI Listing Obligations). The document does not contain the financial results themselves but informs about the meeting where these results will be approved. The document length is short (1817 characters), and it serves as an announcement rather than the report itself. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement about an upcoming board meeting and financial results approval, not the actual Annual Report or Earnings Release.
2025-05-09 English
Board to consider Dividend
Regulatory Filings Classification · 95% confidence The document is a notice of an upcoming Board Meeting scheduled for 16th May 2025 to consider and approve the audited financial results for the quarter and financial year ended 31st March 2025, and to recommend dividends. It is a formal announcement pursuant to regulatory requirements (SEBI Listing Obligations). The document does not contain the financial results themselves but informs about the meeting where these results will be approved. The document length is short (1817 characters) and it serves as a notification rather than a report. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement about a board meeting and upcoming financial results, not the results or report themselves.
2025-05-09 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.